Vilin Bio Med Board of Directors

Get the latest insights into the leadership at Vilin Bio Med. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Madhusudhan ReddyManaging Director
Viswa Prasad SadhanalaWhole Time Director
Dhruv TodiCompany Secretary
Prasanna Lakshmi VennaWhole Time Director
Sasikanth ParitalaNon Executive Independent Director
Veeraiah Chowdary KollaNon Executive Independent Director
Girish MukteviNon Executive Independent Director

Vilin Bio Med Share price

VILINBIO

40.75

1.90 (4.89%)
Last updated on 4 May, 2026 | 12:23 IST
Today's High

40.75

Today's Low

39.00

52 Week Low

18.95

52 Week High

40.75

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Vilin Bio Med FAQs

The board at Vilin Bio Med consists of experienced professionals, including Madhusudhan Reddy, Viswa Prasad Sadhanala, and others, overseeing the company’s strategic and corporate governance.

Directors at Vilin Bio Med are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Madhusudhan Reddy is the current chairman at Vilin Bio Med.

Executive directors at Vilin Bio Med are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Vilin Bio Med adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Vilin Bio Med, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost